Pharma Focus Asia
KP - Choose our fully recyclable blister films

Astex Pharmaceuticals Expands Drug Discovery Collaboration with Merck

Wednesday, August 09, 2023

Astex Pharmaceuticals has recently announced that it has entered into an exclusive global research collaboration and licence agreement with MSD (Merck). 

This strategic partnership is an extension of their existing collaboration and is aimed at combining their respective strengths and resources, particularly benefiting from MSD's comprehensive expertise in the field of oncology. The main objective of this collaboration is to identify and develop small molecules capable of targeting a specific tumour suppressor protein, potentially paving the way for innovative cancer treatments.

Under the terms of this agreement, MSD has been granted an exclusive worldwide licence to spearhead research, development, and eventual commercialisation activities for promising candidate compounds originating from this collaborative effort.

As part of the agreement, Astex will receive an upfront payment of $35 million. Additionally, Astex stands to gain milestone payments linked to key stages of progress, including preclinical studies, clinical trials, regulatory approvals, and sales benchmarks.

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024